Splenic tyrosine kinase (SYK) inhibitors and their possible use in acute myeloid leukemia

  • Sushma Bartaula-Brevik, Marte Karen Lindstad Brattås, Tor Henrik Anderson Tvedt, Håkon Reikvam, Øystein Bruserud
  • Expert Opinion on Investigational Drugs, April 2018, Taylor & Francis
  • DOI: 10.1080/13543784.2018.1459562

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/13543784.2018.1459562